Outcome
    Moderate Evidence
    Effectiveness 3/5

    Phosphatidylserine for Cortisol Reduction

    Phosphatidylserine blunts exercise-induced cortisol spikes and is best used around heavy training rather than for general stress.

    Overview

    Phosphatidylserine is a phospholipid concentrated in neuronal membranes, and the cortisol claim rests on a specific and fairly narrow finding: it blunts the cortisol spike produced by acute stress, particularly hard exercise, rather than lowering resting cortisol in unstressed people. The small crossover trial linked to this pairing found exactly that pattern, with a reduced exercise-induced cortisol rise and better perceived wellbeing but no change in performance. Doses in the useful range are 400 to 800 mg daily, well above the 100 mg found in many cognitive formulas, and the trials are small. This is a plausible, low-risk stress-buffering tool with modest supporting data.

    Verdict

    Likely effective

    Several small randomised and crossover trials show a blunted cortisol response to acute stressors at 400 to 800 mg daily. Sample sizes are in the tens, and effects on resting cortisol in healthy people are not established.

    It buffers spikes, it does not flatten baseline

    Expect a smaller cortisol rise around a stressor. Do not expect a change in an unstressed morning cortisol reading.

    How It Works

    Phosphatidylserine sits on the inner leaflet of neuronal membranes, where it supports receptor function and vesicle handling. The relevant action for cortisol is at the hypothalamic-pituitary-adrenal axis: supplementation appears to increase the sensitivity of glucocorticoid feedback, so the axis switches itself off sooner after a stressor and the total cortisol released is smaller. Membrane composition also affects ACTH signalling at the adrenal cortex, which may explain why the effect is on the amplitude of the response rather than on basal secretion. The dose dependence is unusual: several trials found 400 mg effective where 800 mg was not, suggesting an inverted-U response rather than a simple more-is-better relationship.

    Pathways involved

    HPA axis feedback sensitivity
    ACTH signalling
    Neuronal membrane composition
    Reduced peak cortisol amplitude
    Possible inverted-U dose response

    Dosing & Protocol

    ScenarioDoseFormTiming
    Exercise stress buffering600 to 800 mg dailySoy-derived PSDivided, one dose pre-training
    Psychological stress400 mg dailySoy-derived PSMorning
    Cognitive support dose100 to 300 mg dailySoy or sunflower PSWith food
    Trial ceiling800 mg dailySoy-derived PSDivided
    1. 1

      Match the dose to the goal· From the start

      Cortisol trials used 400 to 800 mg daily. The 100 mg in most nootropic blends is a cognitive dose and has not shown HPA effects.

    2. 2

      Take part of the dose before the stressor· Training days

      In exercise trials the supplement was taken across the day with training on top, so timing one dose pre-session is a reasonable reading of the protocol.

    3. 3

      Give it ten days· Days 1 to 10

      Effects were measured after roughly ten days of loading, not after a single dose.

    4. 4

      Track perceived stress, not lab cortisol· Weekly

      A single salivary cortisol reading is too noisy to interpret at home. Weekly perceived stress and recovery scores are more useful.

    5. 5

      Do not escalate if 400 mg works· Ongoing

      Higher is not reliably better in these trials.

    Check the label maths

    Many products list a phosphatidylserine complex rather than pure PS. Read the milligrams of actual PS per serving before dosing.

    Modern phosphatidylserine is made from soy or sunflower lecithin rather than the bovine cortex material used in early studies, which removes the prion concern but also changes the fatty acid profile. The plant derived forms are what current trials use, so they are the right benchmark for dosing.

    Evidence

    The crossover trial linked to this pairing gave phosphatidylserine to ten trained men before a cycling protocol and measured the hormonal response. Cortisol rose less after supplementation and subjective feelings of wellbeing improved, while exercise capacity itself did not change. With ten participants this is a signal, not proof. Surrounding literature is broadly consistent. Trials using the Trier Social Stress Test have reported blunted salivary cortisol responses at 400 mg daily, with one finding that 800 mg was less effective than 400 mg. Older overtraining research found reduced cortisol during heavy training loads. What is missing is a large trial with a clinically meaningful endpoint rather than a hormone measurement.

    Studies linked to this pairing.

    The influence of phosphatidylserine supplementation on cortisol and exercise capacity

    Score: 5/10
    2008
    crossover
    n=10

    Starks MA, Starks SL, Kingsley M +2 more

    Phosphatidylserine blunted the exercise-induced rise in cortisol and improved perceived wellbeing without changing performance

    View source
    Best linked evidence
    Crossover trial in 10 trained men during exercise
    Linked result
    Blunted exercise cortisol rise and improved wellbeing; no performance change
    Typical effective dose
    400 to 800 mg daily for at least ten days
    Endpoint tested
    Hormone response, not clinical outcome
    Certainty
    Low to moderate, limited by very small samples

    Safety

    Plant derived phosphatidylserine is well tolerated. Reported adverse effects are limited to mild gastrointestinal upset and occasional insomnia at higher doses, and no serious events have been reported at up to 800 mg daily in trials running for several months. The historical caution concerns bovine cortex derived PS and theoretical transmissible spongiform encephalopathy risk. That material is essentially unavailable now, but it is a reason to check the source on the label. Cortisol is also not a villain to be minimised: suppressing the normal stress response in someone with adrenal insufficiency or on corticosteroid therapy is not a neutral act.

    Do not chase a low cortisol number

    Cortisol has essential functions in glucose regulation and immune control. The goal is a proportionate response to stress, not the lowest possible reading.

    Reported effects

    Mild stomach upset
    Insomnia at high evening doses
    Check soy allergy status
    Avoid bovine-derived sources
    Limited pregnancy data

    Interactions & Conflicts

    Phosphatidylserine has no significant cytochrome P450 activity. The interactions that matter involve drugs that themselves act on cholinergic signalling or blood clotting, plus the obvious overlap with corticosteroid therapy.
    Interacts withSeverityMechanismAction
    Corticosteroid therapy
    moderate
    Supplement dampens the HPA response while the drug supplies exogenous glucocorticoidDo not use to counteract prescribed steroids; discuss with the prescriber
    Anticholinergic drugs
    low
    PS supports cholinergic transmission and may oppose the drug effectNote any change in the drug response
    Anticoagulants and antiplatelets
    low
    Phospholipid supplementation has a theoretical effect on clotting surfacesMention it before surgery
    Adrenal insufficiency
    high
    Further blunting of an already inadequate cortisol responseAvoid

    References

    1. Starks MA et al. The effects of phosphatidylserine on endocrine response to moderate intensity exercise. J Int Soc Sports Nutr. 2008
    2. Hellhammer J et al. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex on the endocrine and psychological responses to mental stress. Stress. 2004

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.